Michihiro Yano

1.2k total citations
21 papers, 341 citations indexed

About

Michihiro Yano is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Michihiro Yano has authored 21 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Hepatology. Recurrent topics in Michihiro Yano's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Michihiro Yano is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Michihiro Yano collaborates with scholars based in Japan, Germany and United States. Michihiro Yano's co-authors include Goro Takada, Toshio Suda, Junko Suda, Atsushi Iwama, Hitoshi Nishio, Tomoro Hishiki, Eiso Hiyama, Kohmei Ida, Takaharu Oue and Tatsuro Tajiri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Michihiro Yano

18 papers receiving 337 citations

Peers

Countries citing papers authored by Michihiro Yano

Since Specialization

Citations

This map shows the geographic impact of Michihiro Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiro Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiro Yano more than expected).

Fields of papers citing papers by Michihiro Yano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michihiro Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiro Yano. The network helps show where Michihiro Yano may publish in the future.

Co-authorship network of co-authors of Michihiro Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Michihiro Yano. A scholar is included among the top collaborators of Michihiro Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihiro Yano. Michihiro Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study 2024 ·International Journal of Hematology ·Hirozumi Sano, Keitaro Fukushima, Michihiro Yano, Shinya Osone, Yoko Kato, Daiichiro Hasegawa, Takako Miyamura, Shotaro Iwamoto, Hiroyuki Takahashi, Kiminori Terui, Akio Tawa, Daisuke Tomizawa	0
2	Detailed molecular and pathological analyses of primary intracranial embryonal rhabdomyosarcoma with a BRAF mutation: illustrative case 2023 ·Journal of Neurosurgery Case Lessons ·Masamichi Abe, Takahiro Ono, Felix Hinz, Masataka Takahashi, (unknown), (unknown), Michihiro Yano, Hiroshi Nanjo, Tsutomu Takahashi, Andreas von Deimling, Hiroaki Shimizu	0
3	Current methods of preventing infectious disease and managing febrile neutropenia in childhood cancer patients: a nationwide survey in Japan 2022 ·International Journal of Clinical Oncology ·Shinya Osone, (unknown), Nobuyuki Yamamoto, Koji Suzuki, Michihiro Yano, Yuji Ishida, Yuya Saito, Akihisa Sawada, Hirozumi Sano, Yoko Kato, (unknown), (unknown), (unknown), Shuki Mizutani, Keitaro Fukushima	0
4	Influence of Self-Efficacy on Cancer-Related Fatigue and Health-Related Quality of Life in Young Survivors of Childhood Cancer 2022 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), Michihiro Yano, Arata Watanabe, H. Kodama	10
5	Feasibility of dose‐dense cisplatin‐based chemotherapy in Japanese children with high‐risk hepatoblastoma: Analysis of the JPLT3‐H pilot study 2021 ·Pediatric Blood & Cancer ·Kenichiro Watanabe, Makiko Mori, Tomoro Hishiki, Akiko Yokoi, Kohmei Ida, Michihiro Yano, Junya Fujimura, (unknown), Tomoko Iehara, Ken Hoshino, Takeshi Inoue, Yukichi Tanaka, Osamu Miyazaki, Tetsuya Takimoto, Kenichi Yoshimura, Eiso Hiyama	5
6	Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial 2019 ·Pediatric Blood & Cancer ·Nobuyuki Hyakuna, Yoshiko Hashii, Hiroyuki Ishida, Katsutsugu Umeda, Yoshiyuki Takahashi, Masayuki Nagasawa, Hiromasa Yabe, Yozo Nakazawa, Katsuyoshi Koh, Hiroaki Goto, Hiroyuki Fujisaki, Kimikazu Matsumoto, Harumi Kakuda, Michihiro Yano, Akio Tawa, Daisuke Tomizawa, Takashi Taga, Souichi Adachi, Koji Kato	8
7	Late toxicities, especially second malignancies, with GWAS analysis in hepatoblastoma cases treated in the Japanese study group for pediatric liver tumor protocol-2. 2019 ·Journal of Clinical Oncology ·Eiso Hiyama, Kenichiro Watanabe, Makiko Mori, Kohmei Ida, Tomoro Hishiki, Michihiro Yano, Yukichi Tanaka, Kenichi Yoshimura, Keiko Hiyama	1
8	Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan 2019 ·International Journal of Hematology ·Shinya Osone, Keitaro Fukushima, Michihiro Yano, (unknown), Hirozumi Sano, Yoko Kato, (unknown), (unknown), (unknown), Souichi Adachi	6
9	Occludin Expression in Epidermal γδ T Cells in Response to Epidermal Stress Causes Them To Migrate into Draining Lymph Nodes 2017 ·The Journal of Immunology ·(unknown), Michihiro Yano, (unknown), Michio Tomura, Naoko Nakano	15
10	Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol 2016 ·Journal of Pediatric Surgery ·Eiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, Kohmei Ida, Michihiro Yano, Takaharu Oue, Tomoko Iehara, Ken Hoshino, Katsuyoshi Koh, Yukichi Tanaka, Sho Kurihara, Yuka Ueda, (unknown)	21
11	Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials 2015 ·Journal of Pediatric Surgery ·Eiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, Kohmei Ida, Michihiro Yano, Takaharu Oue, Tomoko Iehara, Ken Hoshino, Katsuyoshi Koh, Yukichi Tanaka, Sho Kurihara, Yuka Ueda, (unknown)	9
12	Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study 2015 ·Blood ·Arata Watanabe, Toshinori Hori, (unknown), Chihaya Imai, Atsushi Ogawa, Motoaki Chin, Hiroyuki Shichino, Yasuo Horikoshi, Keiko Nomura, Yutaka Saikawa, S Yokota, Akiko Inoue, Takashi Taga, Masahiko Okada, Junichi Ueyama, Asayuki Iwai, Michihiro Yano, Yasuhiro Okamoto, Masahito Tsurusawa, Atsushi Kikuta	1
13	Novel mutation in the TMPRSS6 gene with iron‐refractory iron deficiency anemia 2014 ·Pediatrics International ·(unknown), Atsuko Noguchi, (unknown), (unknown), Michihiro Yano, Tsutomu Takahashi	13
14	A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT) 2013 ·Pediatric Surgery International ·(unknown), Eiso Hiyama, Yuka Ueda, (unknown), (unknown), Kenichiro Watanabe, Tomoro Hishiki, Tatsuro Tajiri, (unknown), Michihiro Yano, Satoshi Kondo, Takaharu Oue	15
15	Survival, surgical resectability, and late effects in the hepatoblastoma patients treated by cisplatin plus pirarubicin (CITA) chemotherapy. 2013 ·Journal of Clinical Oncology ·Eiso Hiyama, (unknown), (unknown), Yuka Ueda, Kenichiro Watanabe, Tomoro Hishiki, Tatsuro Tajiri, Kohmei Ida, Michihiro Yano, Satoshi Kondo, Takaharu Oue	1
16	Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT 2010 ·Pediatric Surgery International ·Tomoro Hishiki, Tadashi Matsunaga, Fumiaki Sasaki, Michihiro Yano, Kohmei Ida, Hiroshi Horie, Satoshi Kondo, (unknown), Takaharu Oue, Tatsuro Tajiri, (unknown), Naomi Ohnuma, Eiso Hiyama	100
17	Langerhans cell histiocytosis of the sternum 2009 ·Upsala Journal of Medical Sciences ·Hiroyuki Tsuchie, Kyoji Okada, Hiroyuki Nagasawa, Michihiro Yano, Hiroshi Nanjyo, Yoichi Shimada	7
18	Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings 2003 ·Leukemia ·Naoki Watanabe, Hirofumi Kobayashi, (unknown), M. Yoshida, Atsushi Kikuta, Yoshihiro Komada, Ichiro Sekine, Yasushi Ishida, (unknown), Yukiko Tsunematsu, Michihiro Yano, Hisaya Nakadate, Yasuhiko Kaneko	22
19	Elevated Sphingomyelinase and Hypercytokinemia in Hemophagocytic Lymphohistiocytosis 2002 ·Journal of Pediatric Hematology/Oncology ·Tsutomu Takahashi, Tamaki Abe, Takayuki Sato, (unknown), Ikuko Takahashi, Michihiro Yano, (unknown), (unknown), Goro Takada	18
20	Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells? 1999 ·Bone Marrow Transplantation ·Michihiro Yano, A. Watanabe, Yoshifumi Kawano, Tsutomu Watanabe, Yoichi Takaue	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact